|Synonym||:||Mobiflex;4-Hydroxy-2-methyl-N-2-pyridinyl-2H- thieno[2,3- e ]-1,2-thiazine-3-carboxamide 1,1-dioxide|
|Functions||:||1. Pharmaceuticals>Musculo-Skeletal Disorders>NSAIDs>Phenyl acetic acid>|
|2. Pharmaceuticals>Musculo-Skeletal Disorders>Rubifacients>|
|3. Pharmaceuticals>Skin>Other skin preparations>Seborrhic treatment>|
Progress Life Sciences Pvt. Ltd.(PLS) is a professionally managed rapidly evolving company founded by technocrats with a vision to carry out business globally Tenoxicam: BP/USP. This company has been founded by 1st generation enterprenuers with a strong desire to create a world class generic pharmaceutical and chemical company.
At PLS, we believe that success is defined by the positive impact which we make on the world around us. Since the beginning, our goal has always been to provide access to affordable healthcare solutions to millions of people who are in need.
We are a lean company with skilled,educated & experienced professionals who look after various critical operations on day to day basis and have been successfully able to establish the base for a bigger business platform globally. Our present core focus area remains APIs and intermediates Tenoxicam: BP/USP.
Over a period of time PLS has successfully been able to develop new products, gained market approvals, made commercial supplies to customers of reupte in both domestic and international markets & have created a basket which will bring in growh for the company and its people. Our Products are being exported to LATAM, Middle East and Asian subcontinents.
We plan to venture into formulation and finished dosage business and are open for new ideas for collaborations & believe in co-creation of breakthrough solutions.
Progress curently holds Good manufacturing practices (GMP) license issued by food and drug administration Pune – in accredition to the practices being followed to manufacture the goods therein.
Tenoxicam, sold under the brand name Mobiflex among others, is a nonsteroidal anti-inflammatory drug (NSAID). It is used to relieve inflammation, swelling, stiffness, and pain associated with rheumatoid arthritis, osteoarthritis, ankylosing spondylitis (a type of arthritis involving the spine), tendinitis (inflammation of a tendon), bursitis (inflammation of a bursa, a fluid-filled sac located around joints and near the bones), and periarthritis of the shoulders or hips (inflammation of tissues surrounding these joints). Tenoxicam belongs to the class of NSAIDs known as oxicams. It was patented in 1974 by Roche and approved for medical use in 1987. It is available as a prescription-only drug in the United Kingdom and other countries, but not in the US. Outside the United Kingdom, tenoxicam is also marketed under brand names including Tilatil, Tilcitin, and Alganex.